Skip to main content
. 2022 Aug 18;66(2):435–443. doi: 10.1007/s10840-022-01314-w

Table 2.

One-year freedom from AF: AS-TREATED

Parameter (n = 344) No recurrence
n = 244
Recurrence
n = 100
P-value
Male sex 184 (75%) 67 (67%) 0.073
Age 60 ± 10 (61) 61 ± 10 (62) 0.270
BMI 28 ± 4 (27) 26 ± 4 (27) 0.882
Paroxysmal AF 176 (72%) 52 (53%)  < 0.001
Duration of AF (month) 55 ± 60 69 ± 62 0.392
PLAX (mm) 41 ± 7 (41) 43 ± 6 (42) 0.033
LVEF (%) 58 ± 9 (60) 59 ± 7 (60) 0.130
LAVI (ml/m2) 35 ± 12 (33) 38 ± 11 (37) 0.009
Comorbidities
CAD 11 (5%) 3 (3%) 0.534
Smoking (340) 0.334
  Yes 26 (11%) 15 (15%) 0.516
  No 126 (51%) 53 (53%)
  Past 88 (36%) 32 (32%)
HT 138 (57%) 72 (72%) 0.005
Diabetes 16 (7%) 9 (9%) 0.547
Renal insufficiency 12 (5%) 9 (9%) 0.242
CHADSVASC 0.050
  0 64 (26%) 15 (15%)
  1 70 (29%) 33 (33%)
  2 57 (23%) 21 (21%)
  3 31 (13%) 19 (19%)
  4 17 (7%) 4 (4%)
  ≥ 5 6 (2%) 7 (7%)
Procedural
Procedure duration (min) 106 ± 39 (102) 112 ± 43 (109) 0.152
Fluoroscopy duration (min) 9 ± 7 (8) 9 ± 8 (7) 0.702
RF-PVI at index 181 (74%) 73 (73%) 0.491
SVCI 48 (20%) 27(27%) 0.151
Number of reconnected veins 2.6 ± 1.0 (3) 1.5 ± 1.0 (2) 0.508
0.853
  0 9 (4%) 6 (6%)
  1 38 (16%) 18 (18%)
  2 90 (37%) 34 (34%)
  3 64 (26%) 25 (25%)
  4 43 (18%) 17 (17%)
Location
  LSPV (341) 134 (55%) 53 (53%) 0.904
  LIPV 123 (50%) 47 (47%) 0.720
  RSPV 152 (62%) 55 (55%) 0.226
  RIPV 169 (69%) 68 (68%) 1.000
PVI RF duration 790 ± 482 (713) 795 ± 524 (673) 0.804
SVC duration 49 ± 127 (0) 78 ± 171 (0) 0.096

Values are n (%) for categorical and mean ± standard deviation and median (median) for continuous variables

Duration of AF (n = 337) was defined as the time interval between the first diagnosis of AF and pulmonary vein isolation

AF, atrial fibrillation; AFB, AF burden score; BMI, body mass index; CHADSVASC, (n = 343); PLAX, parasternal long-axis (n = 284); LAVI, left atrial volume indexed (n = 249); LVEF, left ventricular ejection fraction (n = 333)